Repligen Corp

RGENNASDAQ · USD
189.68USD-0.97 (-0.51%)
5910

Repligen Corp (RGEN) Options Open Interest

RGEN options open interest is 14,536 contracts. The 2-week average daily volume is 555 contracts across the chain.

Read more

Monitoring RGEN open interest helps you see where real money is positioned on Repligen Corp's options and which strikes are attracting the most commitment from traders. Repligen Corp's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor RGEN options open interest in real time and find the strikes that matter.

Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising RGEN options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Repligen Corp to settle.

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes.

It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and SpectraFlo dynamic dialysis systems; and ProConnex single-use hollow fiber. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where RGEN open interest is concentrated. Our scanner maps Repligen Corp's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Repligen Corp's options open interest as the signal it is, not as an afterthought.

2026-10-16
Calls
200.005.306.005.6550%+0.37663,219
220.001.502.752.1356%+0.165155
195.007.009.208.1053%+0.463547
190.008.5011.5010.0051%+0.543332
165.0026.0029.5027.7556%+0.874931
Puts
110.00—2.152.15164%-0.0565600
170.000.803.802.3053%-0.1657189
175.001.604.002.8048%-0.209232
165.000.502.801.6555%-0.122823
185.004.607.706.1549%-0.36958

As of September 24, 2026

Follow the money

Track RGEN open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.

Start your 14-day free trial